Skip to main content
. 2010 May 20;13(5):544–549. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2010.05.30

1.

氨柔比星治疗一线治疗SCLC临床研究[3]

Studies of amubicin in first-line treatment

Author Type of study No. of patients Overall response Median survival/month
Yana T, et al[10] Single arm 35 78.8% 11.3
Ohe Y, et al[11] Single arm 44 87.8% 13.6